Publications

456 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:
  1. Teduglutide (Revestive®) for the treatment of short bowel syndrome

    The Minister of Health, Welfare and Sport (VWS) has asked the National Health Care Institute to carry out an assessment of ...

    Report | 31-07-2018

  2. Obeticholic acid (Ocaliva®) for the treatment of primary biliary cholangitis

    The National Health Care Institute carried out an assessment of whether obeticholic acid (Ocaliva®) is interchangeable with a ...

    Report | 18-07-2018

  3. Cariprazine (Reagila®) for the treatment of schizophrenia

    The Minister of Health, Welfare and Sport (WVS) asked the National Health Care Institute  (National Health Care Institute) to ...

    Report | 04-06-2018

  4. Dimethyl fumarate (Skilarence®) for the treatment of plaque psoriasis in adults

    The Minister of Health, Welfare and Sport (WVS) asked Zorginstituut Nederland (National Health Care Institute) to carry out an ...

    Report | 09-05-2018

  5. Flash Glucose Monitoring (FGM)

    In this report the National Health Care Institute assesses whether Flash Glucose Monitoring (FGM) complies with ‘established ...

    Report | 30-04-2018

  6. Rolapitant (Varuby®) for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults

    The National Health Care Institute has carried out an assessment of the medicinal product rolapitant (Varuby®). The GVS report ...

    Report | 17-04-2018

  7. Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)

    The National Health Care Institute has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and ...

    Report | 29-03-2018

  8. Fampridine (Fampyra®) in cases of multiple sclerosis (MS)

    The National Health Care Institute carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the ...

    Report | 01-03-2018

  9. Nusinersen (Spinraza®) for the treatment of 5q Spinal Muscular Atrophy

    The National Health Care Institute  carried out an assessment on the medicinal product nusinersen (Spinraza®) for the treatment ...

    Report | 07-02-2018

  10. Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia

    The National Health Care Institute  issued a package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...

    Report | 18-01-2018